vs

Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.

GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $12.6M, roughly 1.9× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 14.6%, a 236.1% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -25.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -23.9%).

Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.

GENC vs SPRO — Head-to-Head

Bigger by revenue
GENC
GENC
1.9× larger
GENC
$23.6M
$12.6M
SPRO
Growing faster (revenue YoY)
SPRO
SPRO
+24105.7% gap
SPRO
24080.8%
-25.0%
GENC
Higher net margin
SPRO
SPRO
236.1% more per $
SPRO
250.7%
14.6%
GENC
Faster 2-yr revenue CAGR
SPRO
SPRO
Annualised
SPRO
847.7%
-23.9%
GENC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GENC
GENC
SPRO
SPRO
Revenue
$23.6M
$12.6M
Net Profit
$3.4M
$31.5M
Gross Margin
28.7%
Operating Margin
13.2%
Net Margin
14.6%
250.7%
Revenue YoY
-25.0%
24080.8%
Net Profit YoY
-9.8%
250.9%
EPS (diluted)
$0.23
$0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENC
GENC
SPRO
SPRO
Q4 25
$23.6M
$12.6M
Q3 25
$18.8M
$0
Q2 25
$27.0M
$0
Q1 25
$38.2M
$12.0K
Q4 24
$31.4M
$52.0K
Q3 24
$20.9M
$65.0K
Q2 24
$25.6M
$114.0K
Q1 24
$40.7M
$140.0K
Net Profit
GENC
GENC
SPRO
SPRO
Q4 25
$3.4M
$31.5M
Q3 25
$1.9M
$-7.4M
Q2 25
$3.8M
$-1.7M
Q1 25
$6.1M
$-13.9M
Q4 24
$3.8M
Q3 24
$1.5M
$-17.1M
Q2 24
$2.6M
$-17.9M
Q1 24
$6.2M
$-12.7M
Gross Margin
GENC
GENC
SPRO
SPRO
Q4 25
28.7%
Q3 25
24.2%
Q2 25
26.5%
Q1 25
29.7%
Q4 24
27.6%
Q3 24
25.6%
Q2 24
23.9%
Q1 24
30.3%
Operating Margin
GENC
GENC
SPRO
SPRO
Q4 25
13.2%
Q3 25
-1.2%
Q2 25
11.6%
Q1 25
17.0%
-122758.3%
Q4 24
14.7%
Q3 24
5.9%
-28604.6%
Q2 24
7.8%
-16720.2%
Q1 24
17.4%
-9987.1%
Net Margin
GENC
GENC
SPRO
SPRO
Q4 25
14.6%
250.7%
Q3 25
10.2%
Q2 25
14.2%
Q1 25
16.0%
-115550.0%
Q4 24
12.1%
Q3 24
6.9%
-26380.0%
Q2 24
10.0%
-15668.4%
Q1 24
15.3%
-9049.3%
EPS (diluted)
GENC
GENC
SPRO
SPRO
Q4 25
$0.23
$0.56
Q3 25
$0.13
$-0.13
Q2 25
$0.26
$-0.03
Q1 25
$0.42
$-0.25
Q4 24
$0.26
Q3 24
$0.10
$-0.32
Q2 24
$0.17
$-0.33
Q1 24
$0.42
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENC
GENC
SPRO
SPRO
Cash + ST InvestmentsLiquidity on hand
$147.7M
$40.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$215.2M
$59.0M
Total Assets
$228.9M
$68.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENC
GENC
SPRO
SPRO
Q4 25
$147.7M
$40.3M
Q3 25
$136.3M
$48.6M
Q2 25
$136.0M
$31.2M
Q1 25
$143.7M
$48.9M
Q4 24
$130.1M
$52.9M
Q3 24
$115.4M
$76.3M
Q2 24
$116.6M
$63.5M
Q1 24
$117.1M
$82.3M
Total Debt
GENC
GENC
SPRO
SPRO
Q4 25
Q3 25
$0
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
Q1 24
Stockholders' Equity
GENC
GENC
SPRO
SPRO
Q4 25
$215.2M
$59.0M
Q3 25
$211.8M
$26.5M
Q2 25
$209.9M
$32.8M
Q1 25
$206.1M
$33.8M
Q4 24
$200.0M
$46.1M
Q3 24
$196.1M
$65.5M
Q2 24
$194.7M
$80.5M
Q1 24
$192.1M
$96.2M
Total Assets
GENC
GENC
SPRO
SPRO
Q4 25
$228.9M
$68.9M
Q3 25
$222.6M
$54.2M
Q2 25
$220.2M
$62.1M
Q1 25
$223.9M
$77.7M
Q4 24
$218.2M
$110.5M
Q3 24
$208.1M
$135.2M
Q2 24
$201.8M
$149.9M
Q1 24
$206.0M
$167.7M
Debt / Equity
GENC
GENC
SPRO
SPRO
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENC
GENC
SPRO
SPRO
Operating Cash FlowLast quarter
$11.1M
$-8.4M
Free Cash FlowOCF − Capex
$10.1M
FCF MarginFCF / Revenue
43.0%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
3.23×
-0.26×
TTM Free Cash FlowTrailing 4 quarters
$-3.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENC
GENC
SPRO
SPRO
Q4 25
$11.1M
$-8.4M
Q3 25
$-275.0K
$17.4M
Q2 25
$-23.9M
$-17.7M
Q1 25
$12.4M
$-4.0M
Q4 24
$14.8M
$-23.4M
Q3 24
$-3.2M
$12.8M
Q2 24
$-1.0M
$-18.7M
Q1 24
$11.7M
$5.9M
Free Cash Flow
GENC
GENC
SPRO
SPRO
Q4 25
$10.1M
Q3 25
$-1.3M
Q2 25
$-24.4M
Q1 25
$12.3M
Q4 24
$14.5M
Q3 24
$-3.3M
Q2 24
$-1.4M
Q1 24
$11.7M
FCF Margin
GENC
GENC
SPRO
SPRO
Q4 25
43.0%
Q3 25
-6.8%
Q2 25
-90.4%
Q1 25
32.2%
Q4 24
46.1%
Q3 24
-15.8%
Q2 24
-5.6%
Q1 24
28.7%
Capex Intensity
GENC
GENC
SPRO
SPRO
Q4 25
4.1%
Q3 25
5.4%
Q2 25
1.8%
Q1 25
0.4%
Q4 24
1.0%
Q3 24
0.4%
Q2 24
1.5%
Q1 24
0.0%
Cash Conversion
GENC
GENC
SPRO
SPRO
Q4 25
3.23×
-0.26×
Q3 25
-0.14×
Q2 25
-6.24×
Q1 25
2.04×
Q4 24
3.88×
Q3 24
-2.22×
Q2 24
-0.41×
Q1 24
1.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons